 NEW YORK, Sept. 30, 2021 GLOBE NEWSWIRE -- LifeMD, Inc. the Company NASDAQ: LFMD, a rapidly growing direct-to-patient telehealth company today announced the pricing of its previously announced underwritten registered public offering of 1,400,000 shares of its 8.875 Series A Cumulative Perpetual Preferred Stock, par value 0.0001 per share the Series A Preferred Stock, with a total liquidation preference of 35,000,000. In connection with this offering, the Company has granted the underwriters a 30-day option to purchase an additional 210,000 shares of Series A Preferred Stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on October 4, 2021, subject to customary closing conditions. 